✦ LIBER ✦

Threats in bioterrorism II: CDC category B and C agents

✍ Scribed by Moran, Gregory J

Book ID: 122543851
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 113 KB
Volume: 20
Category: Article
ISSN: 0733-8627
DOI: 10.1016/S0733-8627(01)00003-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Threats in bioterrorism I: CDC category

Threats in bioterrorism I: CDC category A agents

✍ Darling, Robert G; Catlett, Christina L; Huebner, Kermit D; Jarrett, David G 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 700 KB

P860 Efficacy and safety of gatifioxacin

P860 Efficacy and safety of gatifioxacin for chronic prostatitis (NIH category II or IIIa) in Korea

✍ S. Lee; M. Kim; C. Kim; B. Shim; D. Kim; C. Han; Y. Ha; Y. Cho 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB

High sensitivity to analogs of ARA-C and

High sensitivity to analogs of ARA-C and topoisomerase I (TOPO I) active drugs in SCLC cells with resistance to TOPO II targeting agents and to alkylating agents

✍ Jensen, P.B.; Holm, B.; Sørensen, M.; Sehested, M.; Hansen, H.H. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Studies on Adrenaline-induced Leucocytos

Studies on Adrenaline-induced Leucocytosis in Normal Man : II. THE EFFECTS OF α AND β ADRENERGIC BLOCKING AGENTS

✍ E. B. French; C. M. Steel; W. R. C. Aitchison 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

An oral Syk kinase inhibitor in the trea

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents

✍ Mark C. Genovese; Arthur Kavanaugh; Michael E. Weinblatt; Charles Peterfy; Julie 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views